Trellus Health Share Discussion Threads

[brummy_git] 29/6/2021 05:21

Just in case you missed it yesterday.

Marvellous insights from Christopher Mills of Harwood Capital - a world class investor - talking about top quality stocks, such as Trellus health.

Heaven personified

www.linkedin.com/posts/paul-hill-a5994116_vox-markets-fund-manager-interview-with-chris-activity-6815288599295123456-BgJJ

[wan] 27/6/2021 12:04

I have received my share certificates too.

[ppmm] 27/6/2021 11:13

Share certificate received

[wan] 26/6/2021 06:33

From the HARGREAVE HALE AIM VCT PLC Half Year Report ending 31 March 2021 -

Page 21 - On 29 January 2021, the VCT received 184,615 Trellus Health Shares through an in-specie distribution from EKF Diagnostics plc. The shares were valued at nil at the balance sheet date.

Investments
The Company has made the following investments since the period end

Page 50 - Trellus Health plc (Amount Invested £000) - 1,000

[wan] 22/6/2021 12:13

ppmm...I am not too fazed by the delay (as I have no intention to sell), but it would be good to get the follow-up call that was indicated, so that I can put in motion what's required in order to lodge the certificates etc.

Btw, if you do phone Link, it seems best to chose the call-back option, which they have responded to on the two occasions that I have used it.

[ppmm] 22/6/2021 10:32

Wan, i’m in the same position and have not yet received my share certificate.

[brummy_git] 19/6/2021 12:30

Trellus Health (9mins 50secs) was also talked about by capital markets expert Jamie Constable of N+1 Singer here yesterday.

www.linkedin.com/posts/paul-hill-a5994116_n1-singer-chief-economist-jamie-constable-activity-6811638461578182656-EjGN

[wan] 19/6/2021 10:35

Given the regulatory issues and compliance etc, the direct process was somewhat demanding but manageable in my view.

Barclays still managed to make life difficult though, and although they eventually supplied the evidence of my EKF holding, their first attempt was incorrect and not even relevant, and the second attempt was not complete as it did not include my SIPP EKF holding. Given the time constraints, I gave up and just sent what Barclays delivered on their second attempt.

Not that I have any intentions to dispose of shares any time soon. I also phoned Link earlier this week as I have not received the share certificates (which will be another bind to administer, including having to lodge the certificates with my broker etc). According to Links records they have already posted the certificates, but would still make further checks to confirm (not sure why they need to check if their records are correct), but I am still waiting for confirmation on this. They will look to re-issue new certificates if 'I think' that the certificates have been lost in the post! As I have not yet had further confirmation either way, I am still unsure as to what happens next.

I too am very impressed with EKF, and I think that EKF have delivered for investors with another excellent IPO and have been further considerate in also making shares available to retail investors by way of the restricted offer. Given the regulatory issues I am not sure whether the process itself could be any smoother, but clearly organisations such as Link and some brokers, could and indeed should have performed better, a lot better, and Barclays Smart Investor gets special mention in this regard!

[ppmm] 19/6/2021 09:49

Duplicated

[ppmm] 19/6/2021 09:49

Good morning James188, I had difficulties with my broker not participating and I was similarly impressed that arrangements were made to allow my participation based on the production of proof of entitlement etc. I was informed that I’d receive something this week, which i’m still waiting for. At least I’m not the only one. Very happy to hold

[james188] 18/6/2021 19:47

I commented earlier on the Restricted Offer procedures for direct applicants, which I thought were pretty clunky.

Having not heard how many shares I had been allocated under the Restricted Offer, I called LINK today to find out what was going on. It was very unsatisfactory experience for a host of reasons and they had no record of my application or whether I had been issued any shares. Frankly, they were very polite, but clueless.

I e-mailed the company direct to ask what the hell was going on. Very impressively, the company secretary (Salim Hamir) called me back almost immediately to give me a very full explanation of the position and to confirm my share allocation. I cannot think of many companies who would bother to do that.

The admin behind the TRLS IPO has clearly been sub par, which is a real shame, given that the IPO itself has been so successful. I think that EKF and the companies that it has spun out are best in class in the way that they deal with retail investors.There are going to be further spin-outs. I think that lessons will be learnt from this one. I am posting this as I believe that there are still some applicants in the dark. The company is on the case.

[rivaldo] 16/6/2021 15:15

The Amati AIM VCT this afternoon released their monthly factsheet, and had this to say FYI:



"New investments were made in Trellus Health, an IPO spin out from Mount Sinai facilitated by EKF Diagnostics. Trellus is commercialising 20 years of research by the academic founders who created the GRITT programme to help irritable bowel disorder (IBD) patients increase their resilience to the social-mental and ultimately biological aspects of their disease. Evidence shows that IBD patients with greater resilience are better able to self-manage their symptoms and become a lower burden on the healthcare system. Trellus is developing an AI powered platform to on-board, assess and guide patients through the GRITT programme with the help of a small healthcare team as well as deploy the GRITT methodology into other chronic disease areas."

[wan] 16/6/2021 08:43

Trellus has a great team, including experienced leaders/founders with real passion, commitment, vision and a genuine mission to improve patients lives, which the following exemplifies -

Trellus Health Co-Founder, Dr. Marla Dubinsky MD, Receives Uniting to Care & Cure Award from CCF
Media Coverage | June 14, 2021
Trellus Health Co-Founder, Dr. Marla Dubinsky, MD, was recently honored with the 2021 Uniting to Care & Cure Award from the Crohn’s & Colitis Foundation (CCF).

The award recognizes healthcare providers who have shown exceptional dedication to the Inflammatory Bowel Disease (IBD) community of patients and caregivers, and for advancing the CCF mission to improve patient quality of life and find cures for IBD.

Full release -

[wan] 16/6/2021 08:34

Obviously IBD is a chronic condition, and we know that Trellus will also eventually abe offering personalised care for other complex/chronic conditions.

The following recent interview indicates that virtual chronic care management is accelerating, fuelled by the rapid adoption of telehealth -

The Clinic by Cleveland Clinic CEO points to telehealth's future
Frank McGillin talks about "on-demand" virtual care, virtual second opinions, chronic care management via telemedicine and telehealth personalization.
By
Bill Siwicki
June 14, 2021

Demand for "on-demand" telehealth services will grow, technology will normalize access to health experts via telemedicine, virtual chronic care management is growing and personalization will influence telehealth engagement.

Q: Do you believe demand for "on-demand" virtual care will grow? If so, why?

A: The horse is out of the barn for virtual care. COVID-19 eliminated many of the barriers to virtual care that existed before the pandemic, from provider reluctance to lack of infrastructure to hesitance from consumers.

Now, people are finding that they like the convenience of virtual care – especially when they can get it on demand. One physician-consumer survey found more than half of consumers plan to use telehealth more after the pandemic than they did beforehand, while 92% of physicians expect to continue providing virtual care.

Q: What is the outlook for virtual chronic care management?

A: Virtual chronic care management is accelerating. It's a trend fueled not only by the rapid adoption of telehealth, but also the creative use of remote patient monitoring technologies to monitor and manage individuals' health.

Full article -

[wan] 14/6/2021 07:42

With perhaps some relevance to the above post, a couple of slides from EKF's 2021 – 2024 Growth Strategy that in my opinion also has some relevance here -

2. Exploit newly expanded capabilities to meet the demand for
contract manufacturing services
Leverage relationship with private sector partner to support their diagnostics strategy
EKF currently makes kits for their COVID sample collection product in USA,
UK and Germany
Customer is the largest distribution business in the world
Leveraging distribution business to move into ‘home diagnostics’
EKF perfect partner due to manufacturing capabilities in US, Europe and UK
EKF also a key regulatory partner
Collaborating on new molecular enzyme product to be made in Elkhart
Reliant on EKF for all diagnostic advice
Increasing demand for kit manufacturing
Substantial revenue and EBITDA growth opportunity

3. Seek complementary earnings-enhancing acquisitions with
key strategic value to the core business
Three growth areas identified

CLIA lab for diagnostic tests
– Further area of partnership with global private sector partner
– Potential to link to Trellus, Renalytix and Verici
– Move into $4bn US diagnostic testing market which has forecast CAGR of 13% from 2021 to 2027

Molecular assay and platform
– Plug and play assays providing simplified workflows and cost-effective logistics
– In-house molecular assays and development of assays for major platform providers
– Potential Point Of Care (POC) molecular instrument

Expansion of kitting capabilities
– Contract manufacturing for existing diagnostics companies
– Adding to our existing capabilities in USA, UK and Germany

[wan] 11/6/2021 12:06

Food for thought (given EKF's connection with a very large private sector partner)-

Amazon attracting multiple companies to telehealth service
An Amazon exec said that the organization has had "quite a bit of interest from other companies in using this service," according to CNBC.
By
Kat Jercich
June 10, 2021

Amazon Care has signed several companies to its telehealth service, an executive said during a Wall Street Journal event on Wednesday, as the consumer giant continues with plans to roll out the service to all 50 states by this summer.

Speaking at the WSJ Tech Health event, Amazon VP Babak Parviz said that "we’ve had quite a bit of interest from other companies in using this service," according to CNBC.

"We are planning to expand the digital component of this in the next few months to every state in the U.S.," said Parviz. "We'll also make it available to other company employees, besides Amazon, to use this, should they choose to sign up and use the service.

"The plan is to expand the service nationwide," he said.

ON THE RECORD

"Amazon Care is a healthcare service that is 'cyber physical' – it's hybrid. It's part digital, part physical," said Parviz.

"It’s quite different from anything we’ve had in the past," he added.

Full story -

[wan] 02/6/2021 08:49

Most readers will now be familiar with Trellus Health's Technology platform and intellectual property. So just as a quick reminder, the Company’s connected health solution will be enabled through an integrated suite of technology and IP to enable scalable remote access for the Company’s care team, patients, and their health care providers, which importantly is not limited to IBD.

The primary components of the Company’s connected health solution include:
(1) TrellusElevateTM platform
(2) HIPAA-Compliant telehealth platform
(3) GRITTTM resilience assessment and personalised care plans
(4) Quad4XTM risk stratifier
(5) Digital education and behavioural tools
(6) Remote patient monitoring of symptoms, biomarkers, behaviours

And to just underscore that; Trellus secured an exclusive license from ISMMS to commercialise the patentpending GRITT™ methodology across seven chronic disease categories.

While the original GRITTTM resilience assessment was developed specifically for the IBD population, the Company considers that it can be adapted to other chronic conditions with minor refinements.

The following is a sponsored article, thus it provides both a relevant flavour and notable insights into the large and rapidly developing telehealth opportunity, not to mention that part of Trellus Health's business model includes sharing healthcare savings, which even at this early stage of telehealth adoption, appears to be substantial-

The next frontier in specialty care: How telehealth is expanding its reach by making it more accessible, affordable, and higher quality

By Dr. Keith H. Bachman – Kaiser Permanente
Jun 1, 2021

Few things can impact employer health care costs like specialty care needs. This broad category of advanced medical care deals with treatment-intensive conditions such as heart disease, depression, and cancer just to name a few. So, it makes sense that employers should always take a long look at the value of any provider’s specialty care services, especially in light of rising health care costs.

But employers may be surprised to learn that there’s a new differentiating factor that can help evaluate top-notch specialty care: telehealth.

This new virtual specialty care horizon came into sharp focus during the pandemic-driven growth and consumer acceptance of telehealth over the last year—by some estimates, telehealth use jumped more than 3,000% in 2020. And consider this: prior to Covid-19, less than 40% patients with a chronic condition had a telehealth visit. That number now stands at 60%. Just as notable: 53% patients of patients with a chronic condition now say that telehealth provided the same or better quality of care as an in-person visits, versus just 28% general population.

Employers should also note a recent a Government Accountability Office study of Medicare Advantage plans revealed that telehealth services helped to save $500 million in costs. A further study by Anthem found savings of more than $200 per care interaction due to telehealth efficiencies, including helping to reduce redundant tests and unnecessary medications, all without a dip in the quality of care.

Virtual care also has the potential to greatly improve access to advanced care in rural counties, where it may otherwise be lacking. Now specialists are freed up to provide care across a wide geographic area, saving travel time and expense. And If a patient needs to move an appointment, it can be reset quickly with no need to wait till the provider’s next trip to a patient’s area.

Full story -

[davr0s] 01/6/2021 17:33

Ugh - I've got a naff sized position. Hardly cover the trading costs lol

[luffness] 01/6/2021 15:54

Spoke to HL not applied yet but allocations were 6.5% of applications apparently

[adobbing] 01/6/2021 14:38

Just checked my Interactive Investors account and can now see what I got.
My £1000 pledge should have got me 2500, I got just 162, but these do now appear as tradeable.
The balance has been returned to the account as cash and so I’ve just bought £1000 worth for 70.4p

Just in case any other II holders were wondering what had happened.

[nimbo1] 01/6/2021 14:38

Hi wan - good to see you here. In a moment of madness I didn't own EKF before the ex div in specie date for trellus so have been begun buying a stake in the open market.

TAM clearly huge - and out of interest listing market value is the same cap as renx when it listed on aim...